liverfast logo provides early detection of liver disease conditions in type-2 diabetic patients.


LIVERFASt™ provides the right diagnosis of liver disease conditions in type 2 diabetes patients

LIVERFASt™ Fibrosis Score Similar Performance for Cirrhosis: Type 2 Diabetics versus Non-Diabetics

Screening for NAFLD in patients with Metabolic Syndrome (MetS) and Type 2 Diabetes

Type 2 Diabetes & NAFLD Diagnosis: LIVERFASt™ Highly Correlates with Liver Biopsy Staging

References: Chalassani N., et al. Hepatology, 67: 328-357 | Aravind A., et al. Journal of Intelligent Learning Systems and Applications. 2020;12:31-49.| De Ledinghen V., et al. Hepatology 2020.72;1(Suppl):906A | Raskin M., et al. Hepatology 2020.72;1(Suppl):273A | Cohn B., et al. Hepatology 2020.72;1(Suppl):943A

How LIVERFASt™ Works?

LIVERFASt™ Test, provides earlier detection of liver disease condition in type 2 diabetes patients.

What LIVERFASt™ does?

LIVERFASt™ test, delivering/providing the right diagnosis of liver disease conditions in type 2 diabetes patients.

01. Diagnosis

02. Screening

03. Monitoring

Why LIVERFASt™ is your best liver diagnostic tool for diabetic patients?

  • Identifying presence of fatty liver in Diabetic patients.
  • Better applicability and reliability compared to other routine liver test such as LFT, ultrasound or TE.
  • Determines the presence of liver fibrosis, steatosis and inflammation.

Our sales team is here to help you!